{Reference Type}: Editorial
{Title}: Daily oral ibandronate with adjuvant endocrine therapy in postmenopausal women with estrogen receptor-positive breast cancer: editorial commentary.
{Author}: Coleman R;
{Journal}: Ann Transl Med
{Volume}: 12
{Issue}: 4
{Year}: 2024 Aug 1
{Factor}: 3.616
{DOI}: 10.21037/atm-2023-3